Merck: Navigating the Patent Cliff and Future Growth Prospects
Join us as we dissect Merck's stock potential and the challenges it faces with the impending patent cliff of Keytruda. Can this pharmaceutical giant maintain its edge in the market...
Search fresh public links, source activity, and ready-to-use post angles for Merck.
Fresh curated links around Merck are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Join us as we dissect Merck's stock potential and the challenges it faces with the impending patent cliff of Keytruda. Can this pharmaceutical giant maintain its edge in the market...
Merck is making advances in the lucrative ulcerative colitis field with the key prize of its $11 billion buyout from several years ago.
Merck’s Bengaluru GCC to bring together approximately 3,300 professionals
Study results accrued so far are giving Merck greater conviction that the therapy, licensed from a China-based biotech, was worth placing into a sprawling Phase 3 program.
Merck Korea Managing Director Kim Woo-kyu, fourth from left, cuts cake to celebrate the 40th anniversary of the company's Ansan production site during a ceremony at the plant in Gy...
Rahway-based Merck Animal Health, a division of Merck & Co., Inc., announced that it has signed a definitive agreement to acquire TARGAN, a privately held innovator in developi...
Merck KGaA has committed $50 million to build a new biotech with prolific life science investor Versant Ventures, with the ultimate goal of devouring the NewCo down the line.
The endometrial cancer trial is the first of 17 late-stage studies Merck is running for a therapy that’s important to its ambitions of hitting $70 billion in annual sales next deca...
Raleigh, North Carolina, United States, June 11, 2026 — TARGAN Inc, a privately held innovator in developing and commercializing biodevice solutions to improve performance outcomes...
AI drug design specialist Protillion has inked a $510 million biobucks collaboration and license agreement with Merck & Co. that brings together Protillion’s platform and Merck...
Merck Laying Me Off Did Me A Favor Anonymous (not verified) Wed, 06/17/2026 - 23:57 field_thread_url https://cafepharma.com/boards/threads/merck-laying-me-...
Merck Laying Me Off Did Me A Favor Anonymous (not verified) Sun, 06/28/2026 - 03:03 field_thread_url https://cafepharma.com/boards/threads/merck-laying-me-...
Merck KGaA’s U.S. research site has instituted a new in-office work requirement that may lead to the imminent departure of as many as 70 staffers.
Merck & Co. has nixed the phase 2 study of a potential Alzheimer’s disease medicine after the drug underwhelmed in an interim analysis, marking another blow for the pharma’s st...
Replimune’s application is the latest example of changing attitudes at the FDA. Elsewhere, Revolution Medicines outlined more RAS-blocking data and a Definium stock offering brough...
The results were seen by Wall Street analysts as “direct proof-of-concept” that sac-TMT, a drug Merck views as a “cornerstone,” could be part of a future treatment standard for fro...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.